Expertise in
9
conditions

Norbert Gattermann

Head & Neck Surgery, 
Duesseldorf, NW, DE 
Expertise in
9
conditions
Head & Neck Surgery, 
Duesseldorf, NW, DE 
OverviewLocationsClinical Research

Overview

Norbert Gattermann practices in Duesseldorf, Germany. Mr. Gattermann is highly rated in 9 conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome (MDS), Hemolytic Transfusion Reaction, Chronic Myelogenous Leukemia (CML), Bone Marrow Aspiration, and Bone Marrow Transplant.

His clinical research consists of co-authoring 121 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Head & Neck Surgery, Duesseldorf, NW, Germany
Other Locations
Mooren Str. 5, Duesseldorf, NW 40225, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase-Ib/II Study of Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary Myelofibrosis
A Phase-Ib/II Study of Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary Myelofibrosis
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drug: INCB018424/CC-4047
Study Phase: Phase 1/Phase 2
A Randomised, Single-blind, Placebo-controlled, Phase 1, Single-ascending and Multiple-dose Study in Adult Subjects With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome to Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124.
A Randomised, Single-blind, Placebo-controlled, Phase 1, Single-ascending and Multiple-dose Study in Adult Subjects With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome to Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124.
Enrollment Status: Completed
Publish Date: January 03, 2024
Intervention Type: Drug
Study Drug: SLN124
Study Phase: Phase 1
Efficacy and Safety of Pegylated Proline Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients With Chronic Myeloid Leukemia (CML) Who Discontinue ABL-Kinase Inhibitor Therapy - a Randomized Phase III, Multicenter Trial With Post-study Follow-up
Efficacy and Safety of Pegylated Proline Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients With Chronic Myeloid Leukemia (CML) Who Discontinue ABL-Kinase Inhibitor Therapy - a Randomized Phase III, Multicenter Trial With Post-study Follow-up
Enrollment Status: Completed
Publish Date: March 31, 2023
Intervention Type: Drug, Other
Study Drug: AOP2014 / Pegylated-Proline-Interferon Alpha-2b
Study Phase: Phase 3
View 2 Less Clinical Trials

121 Total Publications

Feasibility of a virtual reality (VR)-supported mindfulness intervention for patients with cancer during chemotherapy
Feasibility of a virtual reality (VR)-supported mindfulness intervention for patients with cancer during chemotherapy
Journal: Psychotherapie, Psychosomatik, medizinische Psychologie
Published: December 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gattermann's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile